BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16753365)

  • 21. The role of lymphadenectomy in the treatment of transitional cell carcinoma of the upper urinary tract.
    Komatsu H; Tanabe N; Kubodera S; Maezawa H; Ueno A
    J Urol; 1997 May; 157(5):1622-4. PubMed ID: 9112490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors for survival in patients with transitional cell carcinoma of the bladder: evaluation by histopathologic grade, pathologic stage and flow-cytometric analysis.
    Lee SE; Park MS
    Eur Urol; 1996; 29(2):193-8. PubMed ID: 8647146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of circulating cytotoxic lymphocytes against autologous tumors in patients with bladder cancer.
    Mizutani Y; Okada Y; Terachi T; Yoshida O
    J Urol; 1996 Mar; 155(3):888-92; discussion 892-4. PubMed ID: 8583600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A clinical study on transitional cell carcinoma of the renal pelvis and ureter].
    Yoshino S; Takahashi T; Tachibana Y; Kokuho M; Yamauchi T; Kawai T
    Hinyokika Kiyo; 1990 May; 36(5):541-7. PubMed ID: 2399855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tumors of the upper urinary tract].
    Ferrero Doria R; Guzmán Martínez-Valls PL; Morga Egea JP; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Fontana Compiano LO
    Actas Urol Esp; 1998 May; 22(5):410-6. PubMed ID: 9675921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephroureterectomy: rationale in the management of transitional cell carcinoma of the upper urinary tract.
    Cummings KB
    Urol Clin North Am; 1980 Oct; 7(3):569-78. PubMed ID: 7456169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Transitional cell carcinoma of the upper urinary tract following total cystectomy for bladder cancer].
    Hayashi Y; Tawada T; Ando Y
    Hinyokika Kiyo; 1992 Sep; 38(9):1015-8; discussion 1018-9. PubMed ID: 1414752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors of primary transitional cell carcinoma of the upper urinary tract.
    Lee SH; Lin JS; Tzai TS; Chow NH; Tong YC; Yang WH; Chang CC; Cheng HL
    Eur Urol; 1996; 29(3):266-70; discussion 271. PubMed ID: 8740029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transitional cell carcinoma of the upper urinary tract: analysis of morphology and distribution for surgical management.
    Fujimoto H; Tobisu K; Mizutani T; Sakamoto M; Kakizoe T
    Jpn J Clin Oncol; 1993 Oct; 23(5):303-8. PubMed ID: 8230755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary carcinoma of the renal pelvis and ureter. Evaluation of clinical and pathologic features.
    Strobel SL; Jasper WS; Gogate SA; Sharma HM
    Arch Pathol Lab Med; 1984 Sep; 108(9):697-700. PubMed ID: 6547821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of tumour grade, stage, number and size, smoking habits and sex on the recurrence rate and disease-free interval in patients with transitional cell carcinoma of the bladder.
    Raitanen MP; Tammela TL
    Ann Chir Gynaecol; 1995; 84(1):37-41. PubMed ID: 7645909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A clinicopathological study on carcinoma of the renal pelvis and ureter].
    Hashimoto H; Saga Y; Tokumitsu M; Yamaguchi S; Morikawa M; Yachiku S
    Hinyokika Kiyo; 1997 Oct; 43(10):707-12. PubMed ID: 9395905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histopathological review of transitional cell carcinoma of the upper urinary tract.
    Auld CD; Grigor KM; Fowler JW
    Br J Urol; 1984 Oct; 56(5):485-9. PubMed ID: 6534449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A clinical study of 33 cases of renal pelvic and ureteral tumors].
    Yamaguchi S; Nishihara M; Niibori D; Hashimoto H; Tokunaka S; Inada F; Yachiku S
    Hinyokika Kiyo; 1988 Sep; 34(9):1579-87. PubMed ID: 3213793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A clinical study of associated bladder cancer in patients with renal pelvic and ureteral cancer].
    Togashi M; Toyota K; Kashiwagi A; Asano Y; Nagamori S; Seki T; Koyanagi T; Maru A
    Hinyokika Kiyo; 1990 Oct; 36(10):1141-7. PubMed ID: 2264542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transitional cell carcinoma of upper urinary tract: some prognostic indicators.
    Gawley WF; Harney J; Glacken P; Hehir M; Rogers A; McKelvie G
    Urology; 1989 Jun; 33(6):459-61. PubMed ID: 2728147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Endo-urologic surgery of urothelial tumors of the upper urinary tract].
    Martínez-Piñeiro JA; Hidalgo Togores L; Martínez-Piñeiro L; Cózar Olmo JM; Moreno JA
    Arch Esp Urol; 1991 Jun; 44(5):529-39. PubMed ID: 1722082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transitional cell carcinoma of the ureter with an inverted growth pattern which was accompanied with bladder tumor: a case report].
    Tamura Y; Sekihara T; Makino T; Sibayama K; Hirato J
    Hinyokika Kiyo; 1990 Aug; 36(8):945-8. PubMed ID: 2239598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A clinical study of renal pelvic and ureteral cancer associated with bladder cancer].
    Sakaue K; Kakimoto K; Oda M; Kajikawa J; Koide T; Kobayashi Y
    Hinyokika Kiyo; 1996 Feb; 42(2):91-4. PubMed ID: 8712094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.